Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 7, 2015, Pages 1621-1625

  Souty, Cécile ^a,b   Blanchon, Thierry ^a,b   Bonmarin, Isabelle ^c   Lévy Bruhl, Daniel ^c   Behillil, Sylvie ^d   Enouf, Vincent ^d   Valette, Martine ^d,e   Bouscambert, Maude ^d,e   Turbelin, Clément ^a,b   Capai, Lisandru ^a,b,f   Roussel, Victoire ^a,b   Hanslik, Thomas ^a,g,h   Falchi, Alessandra ^f  

^a INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d INSTITUT PASTEUR   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITÉ DE CORSE   (France)

^g HÔPITAL AMBROISE PARÉ   (France)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

France; Influenza; Influenza like illness; Primary care; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ADULT; AGED; ARTICLE; CHILD; DATA PROCESSING; DISEASE ASSESSMENT; DISEASE SURVEILLANCE; DRUG EFFICACY; FRANCE; GENERAL PRACTICE; HUMAN; INFECTION RATE; INFLUENZA A (H3N2); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; RISK FACTOR; SEASONAL INFLUENZA; SYMPTOM ASSESSMENT; WINTER; AGE; HEALTH SURVEY; IMMUNOLOGY; INFLUENZA, HUMAN; SEASON; VACCINATION;

AGE FACTORS; AGED; FRANCE; GENERAL PRACTICE; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; POPULATION SURVEILLANCE; SEASONS; VACCINATION; VACCINE POTENCY;

EID: 84944453029     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1046661     Document Type: Article

References (23)

1. Ministère des Affaires sociales de la Santé et des Droits des femmes (Paris). [2014 vaccination schedule and recommendations]. Paris: The institute; 2014.
2. Broberg E, Snacken R, Adlhoch C, Beaute J, Galinska M, Pereyaslov D, Brown C, Penttinen P; WHO European Region and the European Influenza Surveillance Network. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill 2015; 20(4):pii: 21023; PMID:25655052
3. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, january 2015. MMWR Morb Mortal Wkly Rep 2015 Jan 16; 64(1):10-5; PMID:25590680
4. Pebody RG WF, Ellis J, Andrews N, Thompson C, von Wissmann B, Green HK, Cottrell S, Johnston J, de Lusignan S, Moore C, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill 2015; 2015; 20(5):pii=21025
5. Skowronski D, Chambers C, Sabaiduc S, De Serres G, Dickinson J, Winter A, Drews SJ, Fonseca K, Charest H, Gubbay JB, et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada s Sentinel Physician Surveillance Network, January 2015. Euro Surveill 2015; 20(4):pii: 21022; PMID:25655053
6. Lee CS, Lee JH. Dynamics of clinical symptoms in patients with pandemic influenza A (H1N1). Clin Microbiol Infect 2010 Apr; 16(4):389-90; PMID:20222893
7. Turbelin C, Pelat C, Boelle PY, Levy-Bruhl D, Carrat F, Blanchon T, Hanslik T. Early estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases. Euro Surveill 2009; 14(39):pii: 19341; PMID:19814965
8. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007 Jun; 36(3):623-31; PMID:17403908; http://dx. doi. org/10. 1093/ije/dym021
9. Flahault A, Blanchon T, Dorleans Y, Toubiana L, Vibert JF, Valleron AJ. Virtual surveillance of communicable diseases: a 20-y experience in France. Stat Methods Med Res 2006 Oct; 15(5):413-21; PMID:17089946
10. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995- 1996 epidemic in France. Clin Infect Dis 1999 Feb; 28 (2):283-90; PMID:10064245; http://dx. doi. org/ 10. 1086/515117
11. Falchi A, Turbelin C, Andreoletti L, Arena C, Blanchon T, Bonmarin I, Hanslik T, Leruez-Ville M, De Lamballerie X, Carrat F. Nationwide surveillance of 18 respiratory viruses in patients with influenza-like illnesses: a pilot feasibility study in the French Sentinel Network. J Med Virol 2011 Aug; 83(8):1451-7; PMID:21638286; http://dx. doi. org/10. 1002/ jmv. 22113
12. Costagliola D, Flahault A, Galinec D, Garnerin P, Menares J, Valleron AJ. A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health 1991 Jan; 81 (1):97-9; PMID:1983924; http://dx. doi. org/10. 2105/ AJPH. 81. 1. 97
13. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10:212-41; PMID:3066628
14. Minodier L, Blanchon T, Souty C, Turbelin C, Leccia F, Varesi L, Falchi A. Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic. Expert Rev Vaccines 2014 Aug; 13(8):1039-48; PMID:24946796; http://dx. doi. org/10. 1586/ 14760584. 2014. 930666
15. Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006 Nov 10; 24(44-46):6605-11; PMID:16806607; http://dx. doi. org/10. 1016/j. vaccine. 2006. 05. 063
16. Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H. Vaccination contre la grippe saisonnière en France en 2010 et 2011: diminution des taux de couverture et facteurs associés. La Presse Médicale 2012; 41(11):e568-e76; http://dx. doi. org/ 10. 1016/j. lpm. 2012. 05. 017
17. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993 Aug; 22(4):742-6; PMID:8225751; http://dx. doi. org/ 10. 1093/ije/22. 4. 742
18. Thomas HL, Andrews N, Green HK, Boddington NL, Zhao H, Reynolds A, McMenamin J, Pebody RG. Estimating vaccine effectiveness against severe influenza in England and Scotland 2011/2012: applying the screening method to data from intensive care surveillance systems. Epidemiol Infect 2014 Jan; 142(1):126-33; PMID:23591102
19. Bonmarin I, Belchior E, Le Strat Y, Levy-Bruhl D. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill 2012; 17(18):pii: 20163; PMID:22587956
20. Neuzil KM, Victor JC. Editorial Commentary: Annual Studies of Influenza Vaccine Effectiveness: Evaluating Performance, Informing Policy, and Generating New Questions. Clinical Infectious Diseases 2014 February 1, 2014; 58(3):328-9; http://dx. doi. org/10. 1093/cid/ cit739
21. Turbelin C, Boëlle P-Y. Improving general practice based epidemiologic surveillance using desktop clients: the French Sentinel Network experience. Stud Health Technol Inform. 2010; 160(Pt 1):442; PMID:20841725
22. Falchi A, Souty C, Grisoni ML, Mosnier A, Hanslik T, Daviaud I, Varesi L, Kerneis S, Carrat F, Blanchon T. Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season. Hum Vaccin Immunother 2013 Nov; 9(11):2453-9; PMID:23811610; http://dx. doi. org/10. 4161/hv. 25513
23. Remschmidt C, Rieck T, Bödeker B, Wichmann O. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany. BMC Infectious Diseases 2015; 15(1):137; PMID:25887460; http://dx. doi. org/10. 1186/s12879- 015-0882-3